Item
SODIUM ASCORBATE STD USP/FCC WEI (3920031 215 01M)
Food Chemical
Locations
| Location name | Address |
|---|---|
| CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | No.898 Zhongshan East Road Hi-tech Industrial Development Zone Shijazhuang, China 050035 CHN |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| BSE - TSE | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | 10. VC-Na BSE TSE free Statement.pdf | 8/14/2023 | 8/13/2026 |
| Nutrition | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | 12. Nutritional_values_VC-Na.pdf | 1/1/2023 | 12/31/2025 |
| Label Sample | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | 4.label-NA.jpg | 11/10/2023 | 11/9/2024 |
| CoA Sample | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | COA Sample- Sodium Ascorbate.pdf | 11/10/2023 | 11/9/2025 |
| Country of Origin | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | Country of Origin.pdf | 6/4/2024 | 6/4/2027 |
| HACCP | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | HACCP Plan NA CA.pdf | 1/1/2023 | 12/31/2025 |
| Halal | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | Halal CSPC product list-new.pdf | 7/28/2022 | 7/27/2026 |
| Kosher | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | OU-kosher20240831.pdf | 8/22/2023 | 8/31/2024 |
| Product Specification Sheet | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | Specification of VC-Na 2022.pdf | 1/1/2022 | 12/31/2024 |
| FSVP Assessment Form | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC and VC-Na FSVP Statement.pdf | 11/15/2023 | 11/14/2024 |
| Organic | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC -Na non-organic Statement.pdf | 11/15/2023 | 11/15/2026 |
| Allergens | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-Na Allergen free Statement.pdf | 4/22/2022 | 4/21/2024 |
| HACCP Process Flow Diagram | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-Na CCP flowchart.pdf | 10/11/2022 | 10/10/2024 |
| EtO Statement | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-Na ETOfree Statement.pdf | 11/15/2023 | 11/14/2025 |
| Gluten | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-Na Gluten free Statement.pdf | 2/6/2023 | 2/6/2024 |
| GRAS/NDI/ODI Statement | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-Na GRAS Statement.pdf | 11/15/2023 | 11/14/2026 |
| Heavy Metal | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-Na Heavy Metal Statement.pdf | 5/1/2022 | 4/30/2024 |
| Ingredient Statement | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-Na Ingredient Statement.pdf | 8/14/2023 | 8/13/2024 |
| Irradiation Status Statement | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-Na irradiation Statement.pdf | 11/9/2023 | 11/8/2025 |
| Lot Code | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-Na Lot number explanation Statement.pdf | 6/1/2022 | 5/31/2025 |
| No Animal Ingredient Statement | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-Na no animal ingredient Statement.pdf | 11/15/2023 | 11/14/2024 |
| Animal Testing Statement | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-Na no animal test Statement.pdf | 11/9/2023 | 11/8/2025 |
| GMO | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-Na Non-GMO Statement.pdf | 4/29/2022 | 4/28/2024 |
| Pesticide | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-Na pesticide or herbicide Free statement.pdf | 5/1/2022 | 4/30/2024 |
| Phthalate Esters Letter | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-Na Phthalate Esters Statement.pdf | 11/15/2023 | 11/14/2024 |
| California Prop. 65 | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-Na pro65 Statement.pdf | 11/15/2023 | 11/14/2025 |
| Residual Statement | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-Na Residual Solvents Statement.pdf | 8/14/2023 | 8/13/2024 |
| Safety Data Sheet (SDS) | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-Na SDS 2022.pdf | 6/1/2022 | 5/31/2025 |
| Sewage Statement | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-Na Sewage Statement.pdf | 11/15/2023 | 11/14/2025 |
| Shelf Life | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-Na Shelf Life Statement.pdf | 9/8/2022 | 9/7/2025 |
| WADA/NSF/NFL Statement | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-Na WADA Statement.pdf | 11/15/2023 | 11/14/2025 |
